Lilly's EloraTZP Brought Up to 77% of Adults With Diabetes to Normal Blood Sugar in Phase 2 Trial
In Lilly's company-presented Phase 2 trial, up to 77% of adults with type 2 diabetes reached normal blood sugar after 48 weeks on EloraTZP, an investigational eloralintide–tirzepatide combination.
Medical Daily ·